Study to Evaluate Preventive Effect of Ayurveda and Homeopathy Treatment in COVID 19

Evaluation of Effect of Composite AYUSH Treatment as Prophylaxis of COVID 19

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024731

Enrollment

Registered

2020-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Samshamani Vati (500 mg twice daily after food with warm water for 15 days), Sudarshan Ghana Vati (250 mg thrice daily after food with warm water for 15 days), Khadiradi Vati (250 mg tw

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are not suffering from active illness due to infecction at the time of inclusion

Exclusion criteria

Exclusion criteria: 1.Subjects suffering from active illness due to infection at the time of inclusion. 2.Subjects suffering from uncontrolled DM, HTN etc. 3. Subjects who are known cases of immune-compromised or autoimmune condition such as HIV. 4.Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Episodes and severity of symptoms of respiratory tract infection (cold, sore throat, dry cough, breathlessness) in subjects who may get direct or indirect exposure to COVID 19 during lockdown in March and April 2020Timepoint: From Baseline till the end of 15 days	—

Secondary

Measure	Time frame
Analysis of adverse events, if anyTimepoint: From Baseline till the end of 15 days;Incidence of COVID 19 infection in study populationTimepoint: From Baseline till the end of 15 days;Requirement of treatment for symptoms developed, if any, during study periodTimepoint: From Baseline till the end of 15 days	—

Countries

India

Contacts

Public ContactDr Harish Daga

Parul Institute of Ayurved

dr.shaileshd@gmail.com9763104451

Outcome results